Overactive Bladder - Results from #2000

Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury - Abstract February 6, 2013

Flexible-dose fesoterodine in elderly adults with overactive bladder: Results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trial - Abstract February 4, 2013

Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity - Abstract February 2, 2013

Association of insulin resistance with overactive bladder in female patients - Abstract January 31, 2013

Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: The SENIOR study - Abstract January 31, 2013

Urgency, detrusor overactivity and posterior vault prolapse in women who underwent pelvic organ prolapse repair - Abstract January 30, 2013

Safety of solifenacin and tolterodine in the treatment of overactive bladder: A meta-analysis - Abstract January 28, 2013

Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception - Abstract January 25, 2013

FDA approves over-the-counter Oxytrol for Women to treat overactive bladder January 25, 2013

BOTOX® (onabotulinumtoxinA) receives U.S. Food and Drug Administration approval for the treatment of overactive bladder for adults who have an inadequate response to or are intolerant of an anticholinergic medication January 24, 2013

Neurogenic lower urinary tract dysfunction - Abstract January 24, 2013

Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: An interim analysis - Abstract January 22, 2013

Effect of concomitant administration of trospium chloride extended release on the steady-state pharmacokinetics of metformin in healthy adults - Abstract January 22, 2013

Severity of overactive bladder symptoms and response to dose escalation in a randomized, double-blind trial of solifenacin (SUNRISE) - Abstract January 16, 2013

Propiverine : A review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms - Abstract January 14, 2013

Subject-controlled stimulation of dorsal genital nerve to treat neurogenic detrusor overactivity at home - Abstract January 11, 2013

Effects of solifenacin in patients with neurogenic detrusor overactivity as a result of spinal cord lesion - Abstract January 10, 2013

Usefulness of total bladder capacity and post-void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients - Abstract January 9, 2013

Pharmacological profile of β(3)-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome - Abstract January 8, 2013

OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: Results of a phase 3 randomized placebo-controlled trial - Abstract January 4, 2013

Page 101 of 122